The Moving Average Convergence Divergence (MACD) for CSD turned positive on November 09, 2026. Looking at past instances where CSD's MACD turned positive, the stock continued to rise in 48 of 54 cases over the following month. The odds of a continued upward trend are 89%.
The Momentum Indicator moved above the 0 level on November 06, 2026. You may want to consider a long position or call options on CSD as a result. In 81 of 94 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 86%.
CSD moved above its 50-day moving average on November 09, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +5.42% 3-day Advance, the price is estimated to grow further. Considering data from situations where CSD advanced for three days, in 287 of 342 cases, the price rose further within the following month. The odds of a continued upward trend are 84%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 51 of 66 cases where CSD's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 77%.
The 50-day moving average for CSD moved below the 200-day moving average on November 09, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CSD declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 76%.
CSD broke above its upper Bollinger Band on November 03, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for CSD entered a downward trend on November 10, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The 10-day moving average for SOLS crossed bullishly above the 50-day moving average on October 14, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 6 of 7 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 86%.
The Momentum Indicator moved above the 0 level on November 09, 2026. You may want to consider a long position or call options on SOLS as a result. In 51 of 61 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 84%.
The Moving Average Convergence Divergence (MACD) for SOLS just turned positive on November 10, 2026. Looking at past instances where SOLS's MACD turned positive, the stock continued to rise in 15 of 22 cases over the following month. The odds of a continued upward trend are 68%.
SOLS moved above its 50-day moving average on November 09, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +12.10% 3-day Advance, the price is estimated to grow further. Considering data from situations where SOLS advanced for three days, in 82 of 102 cases, the price rose further within the following month. The odds of a continued upward trend are 80%.
SOLS may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Aroon Indicator entered an Uptrend today. In 60 of 77 cases where SOLS Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 78%.
The 10-day RSI Indicator for SOLS moved out of overbought territory on October 22, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 12 similar instances where the indicator moved out of overbought territory. In 9 of the 12 cases, the stock moved lower in the following days. This puts the odds of a move lower at 75%.
The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where SOLS declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 84%.
The Tickeron Profit vs. Risk Rating rating for this company is 19 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock better than average.
The Tickeron PE Growth Rating for this company is 41 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 51 (best 1 - 100 worst), indicating steady price growth. SOLS’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 56 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 78 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.809) is normal, around the industry mean (2.284). P/E Ratio (43.871) is within average values for comparable stocks, (-17.137). Projected Growth (PEG Ratio) (0.493) is also within normal values, averaging (1.548). Dividend Yield (0.005) settles around the average of (0.039) among similar stocks. P/S Ratio (2.268) is also within normal values, averaging (48.960).
SOLS | ||
|---|---|---|
OUTLOOK RATING 1..100 | 80 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 78 Overvalued | |
PROFIT vs RISK RATING 1..100 | 19 | |
SMR RATING 1..100 | 56 | |
PRICE GROWTH RATING 1..100 | 51 | |
P/E GROWTH RATING 1..100 | 41 | |
SEASONALITY SCORE 1..100 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
| CSD | SOLS | |
|---|---|---|
| RSI ODDS (%) | N/A | 2 days ago 75% |
| Stochastic ODDS (%) | 2 days ago 77% | 2 days ago 81% |
| Momentum ODDS (%) | 2 days ago 86% | 2 days ago 84% |
| MACD ODDS (%) | 2 days ago 89% | 2 days ago 68% |
| TrendWeek ODDS (%) | 2 days ago 78% | 2 days ago 78% |
| TrendMonth ODDS (%) | 2 days ago 86% | 2 days ago 78% |
| Advances ODDS (%) | 3 days ago 84% | 2 days ago 80% |
| Declines ODDS (%) | 7 days ago 76% | 7 days ago 84% |
| BollingerBands ODDS (%) | 2 days ago 77% | 2 days ago 78% |
| Aroon ODDS (%) | 2 days ago 78% | 2 days ago 78% |
A.I.dvisor indicates that over the last year, CSD has been closely correlated with Q. These tickers have moved in lockstep 67% of the time. This A.I.-generated data suggests there is a high statistical probability that if CSD jumps, then Q could also see price increases.
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| UMI | 57.41 | 0.65 | +1.15% |
| USCF Midstream Energy Income Fund ETF (UMI) | |||
| PXE | 39.00 | 0.33 | +0.85% |
| Invesco Energy Exploration & Production ETF (PXE) | |||
| BDGS | 36.50 | 0.02 | +0.06% |
| Bridges Capital Tactical ETF (BDGS) | |||
| GCOW | 47.49 | -0.05 | -0.11% |
| Pacer Global Cash Cows Dividend ETF (GCOW) | |||
| IBRN | 34.79 | -0.09 | -0.24% |
| iShares Neuroscience and Healthcare ETF (IBRN) | |||